The mRNA-LNP Vaccine Encoding Viral VP2 Confers Effective Protection Against Very Virulent Infectious Bursal Disease Virus (vvIBDV)
Microorganisms · 04.11.2026 · 14 (11) · 2544
DOI: 10.3390/microorganisms14112544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 04.11.2026. Verfasst von Yulong Zhang und 17 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, the National Natural Science Foundation of China, Heilongjiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Infectious bursal disease (IBD) is an acute, highly contagious, and immunosuppressive disease of poultry caused by the infectious bursal disease virus (IBDV). For more than 30 years, the very virulent IBDV (vvIBDV) characterized by high mortality has been widely prevalent worldwide, inflicting considerable economic losses on poultry-producing regions and thereby hampering the healthy development of the industry. However, the existing live vaccines carry the risk of restoring virulence and are susceptible to interference from maternal antibodies, while inactivated vaccines often result in insufficient protection. Therefore, it is urgent to develop novel vaccines with improved safety and efficacy. In this study, an mRNA vaccine encoding the VP2 protein of vvIBDV was developed for the first time. Efficient protein expression of mRNA-HLJVP2 was confirmed through in vitro transfection experiments. Immunization experiments in chickens demonstrated that the mRNA-HLJVP2-LNP with three different doses induced specific neutralizing antibodies and significantly increased the proportions of IL-4-secreting CD4+ T cells and IFN-γ-secreting CD8+ T cells. In the following challenge experiment, the mRNA-HLJVP2-LNP immunization groups exhibited good protective efficacy, with the single immunization group (20 μg dose) providing effective protection for chickens from death and bursa lesions induced by vvIBDV challenge. This study provides a promising candidate vaccine for the control of the vvIBDV and highlights its potential for clinical application in the prevention of IBD.
Förderung
- the National Key Research and Development Program of China
- the National Natural Science Foundation of China
- Heilongjiang Provincial Natural Science Foundation of China
- the Innovation Program of the Chinese Academy of Agricultural Sciences
- the China Agriculture Research System
- Chinese Academy of Agricultural Sciences Nanfan Special Project
Zitieren
APA
Zhang, Y., Wu, Z., Yu, H., Wang, G., Liu, R., Ling, D., Ke, E., Liu, X., Xu, T., Wang, S., Chen, Y., Liu, Y., Cui, H., Zhang, Y., Duan, Y., Wang, X., Gao, Y., & Qi, X. (2026). The mRNA-LNP Vaccine Encoding Viral VP2 Confers Effective Protection Against Very Virulent Infectious Bursal Disease Virus (vvIBDV). Microorganisms, 14(11), 2544. https://doi.org/10.3390/microorganisms14112544
Vancouver
Zhang Y, Wu Z, Yu H, Wang G, Liu R, Ling D, et al. The mRNA-LNP Vaccine Encoding Viral VP2 Confers Effective Protection Against Very Virulent Infectious Bursal Disease Virus (vvIBDV). Microorganisms. 2026;14(11):2544. doi:10.3390/microorganisms14112544
BibTeX
@article{Zhang2026,
author = {Zhang, Yulong and Wu, Ziwen and Yu, Hangbo and Wang, Guodong and Liu, Runhang and Ling, Dan and Ke, Erjing and Liu, Xianyun and Xu, Tengfei and Wang, Suyan and Chen, Yuntong and Liu, Yongzhen and Cui, Hongyu and Zhang, Yanping and Duan, Yulu and Wang, Xiaomei and Gao, Yulong and Qi, Xiaole},
title = {The mRNA-LNP Vaccine Encoding Viral VP2 Confers Effective Protection Against Very Virulent Infectious Bursal Disease Virus (vvIBDV)},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {11},
pages = {2544},
doi = {10.3390/microorganisms14112544}
}
EUVIMED